More importantly, a recent study reported that the expression of GluN2B is significantly upregulated in the hippocampus of rats with CUMS-induced depression, and specific inhibitors of GluN2B exhibit good antidepressant effects [26]. Here, GRIN2B is linked to depressive symptom measurement.